(Q37274605)

19 August 2017

1 reference

title

Equine herpesvirus-1 myeloencephalopathy: a review of recent developments (English)

1 reference

19 August 2017

Nicola Pusterla

1

1 reference

19 August 2017

W David Wilson

series ordinal

2

1 reference

19 August 2017

John E Madigan

series ordinal

3

1 reference

19 August 2017

Gregory L Ferraro

series ordinal

4

1 reference

19 August 2017

publication date

19 September 2008

1 reference

19 August 2017

published in

The Veterinary Journal

1 reference

19 August 2017

volume

180

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

279-289

1 reference

Acyclovir neurotoxicity: clinical experience and review of the literature.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Development of a real-time polymerase chain reaction assay for rapid diagnosis of neuropathogenic strains of equine herpesvirus-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine herpesvirus type 1: detection of viral DNA sequences in aborted fetuses with the polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

A nested PCR for the detection and differentiation of EHV-1 and EHV-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Detection of equine herpesvirus type 1 using a real-time polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Application of an equine herpesvirus 1 (EHV1) type-specific ELISA to the management of an outbreak of EHV1 abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Detection of equine herpesvirus type 1 by real time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Detection and identification of equine herpesvirus-1 and -4 by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Antibody to neuritogenic myelin protein P2 in equine paresis due to equine herpesvirus 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine herpes myeloencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Rapid, single-step differentiation of equid herpesviruses 1 and 4 from clinical material using the polymerase chain reaction and virus-specific primers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Detection of EHV-1 neuropathogenic strains using real-time PCR in the neural tissue of horses with myeloencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equid herpesvirus 1 (EHV 1) latency: more questions than answers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

7 January 2021

The equine herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine abortion associated with herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Cytokine gene signatures in neural tissue of horses with equine protozoal myeloencephalitis or equine herpes type 1 myeloencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Use of viral loads in blood and nasopharyngeal secretions for the diagnosis of EHV-1 infection in field cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine herpesvirus 1 and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

The spectrum of antiviral activities of acyclovir in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

In-situ hybridization for demonstration of equine herpesvirus type 1 DNA in paraffin wax-embedded tissues and its use in horses with disseminated necrotizing myeloencephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Diagnosis of Equid herpesviruses −1 and −4 by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Detection of equine herpesvirus and differentiation of equine herpesvirus type 1 from type 4 by the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

Equine herpesvirus 1 myeloencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2008.08.004

10.1016/J.TVJL.2008.08.004

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference